FDA Inspection
Department of Defense - ArmyDepartment of Defense - Army – FDA Inspection, Mar 15, 2017
Record Details
This FDA Inspection record concerns Department of Defense - Army, with an inspection on March 15, 2017, issued by the Center for Biologics Evaluation and Research, covering biologics.
View Company Profile
ID · 53083a71-fccd-487a-97cb-78fc0140e1cb
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1006805
- FDA center
- Biologics
- Project area
- Blood and Blood Products
- Outcome
- Form 483 issued
FDA Citations
1- 21 CFR 606.60(b)Equipment calibration frequency
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Department of Defense - Army
6| Date | Classification | Office | Project area |
|---|---|---|---|
| November 12, 2024 | Not classified | Seattle District Office | |
| May 15, 2019 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| February 24, 2015 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| February 26, 2013 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| April 22, 2011 | VAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
Other documents for Department of Defense - Army
- FDA Inspection 1255732 - 2024-11-12
- FDA Inspection 1091692 - 2019-05-15
- FDA Inspection 915802 - 2015-02-24
- FDA Inspection 820252 - 2013-02-26
- FDA Inspection 721822 - 2011-04-22
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.